DARREN BOARD: Open Payments
NPI 1518452283 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 133 payments from 19 companies in 2025. Trend: 2023 $1,988 · 2024 $1,964 · 2025 $2,217
Food & beverage: $2,113Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $578 |
| Janssen Biotech, Inc. | 16 | $299 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $203 |
| GENZYME CORPORATION | 6 | $168 |
| Incyte Corporation | 11 | $144 |
| Amgen Inc. | 9 | $142 |
| UCB, Inc. | 5 | $123 |
| LEO Pharma Inc. | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Organogenesis Inc. | 2 | $48 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, OPZELURA, Otezla, Bimzelx, Winlevi.
Industry payments across CA — which companies pay providers there.
